Last update 21 Nov 2024

Klebsiella pneumoniae tetravalent bioconjugate vaccine (LimmaTech Biologics)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Multivalent vaccine, Conjugated vaccine
Synonyms
Kleb4V
Target-
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication-
Inactive Indication
Klebsiella pneumoniae infection
Originator Organization
GlycoVaxyn AGGlycoVaxyn AG
Active Organization-
Inactive Organization
GSK PlcGSK PlcLimmaTech Biologics AGLimmaTech Biologics AG
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Klebsiella pneumoniae tetravalent bioconjugate vaccine (LimmaTech Biologics)
NCT04959344 / CompletedPhase 1/2
Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V) Administered to Healthy Adults: A FTIH Phase I/II Randomized and Controlled Study
EUCTR2020-005090-26-DE / Unknown statusPhase 1/2
Safety and immunogenicity of a Klebsiella pneumoniae tetravalent bioconjugate vaccine (Kleb4V) administered to healthy adults: A FTIH phase I/II randomized and controlled study.
100 Clinical Results associated with Klebsiella pneumoniae tetravalent bioconjugate vaccine (LimmaTech Biologics)
Login to view more data
100 Translational Medicine associated with Klebsiella pneumoniae tetravalent bioconjugate vaccine (LimmaTech Biologics)
Login to view more data
100 Patents (Medical) associated with Klebsiella pneumoniae tetravalent bioconjugate vaccine (LimmaTech Biologics)
Login to view more data
100 Deals associated with Klebsiella pneumoniae tetravalent bioconjugate vaccine (LimmaTech Biologics)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Klebsiella pneumoniae infectionPhase 2
DE
LimmaTech Biologics AGLimmaTech Biologics AG
05 Jul 2021
Klebsiella pneumoniae infectionPhase 2
DE
GSK PlcGSK Plc
05 Jul 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free